Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia

Erin Hickey,Bryant Clemons,Shawn P Griffin,Jessica Cox,Stephanie D Sutphin,Reshma Ramlal,Lydia Benitez

Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia

2019

Erin Hickey
Bryant Clemons
Shawn P Griffin
Jessica Cox
Stephanie D Sutphin
Reshma Ramlal
Lydia Benitez

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) characterized by responsiveness to chemotherapy and differentiating agents [1]. The current standard of care for the ...

Keywords:

Arsenic trioxide
Acute promyelocytic leukemia
Immunology
Diabetes mellitus
Gastroenterology
Dosing
Medicine
Internal medicine
Oncology
intermediate risk
Text mining

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations